These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2428421)

  • 1. Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients.
    Scatton B; Dennis T; L'Heureux R; Monfort JC; Duyckaerts C; Javoy-Agid F
    Brain Res; 1986 Aug; 380(1):181-5. PubMed ID: 2428421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biogenic amines and metabolites in spinal cord of patients with Parkinson's disease and amyotrophic lateral sclerosis.
    Sofic E; Riederer P; Gsell W; Gavranovic M; Schmidtke A; Jellinger K
    J Neural Transm Park Dis Dement Sect; 1991; 3(2):133-42. PubMed ID: 1716905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord.
    Bertel O; Malessa S; Sluga E; Hornykiewicz O
    Brain Res; 1991 Dec; 566(1-2):54-60. PubMed ID: 1726065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new microdissection technique for regional biochemical analysis of the rat spinal cord: serotonin, norepinephrine, dopamine and uric acid.
    Basbaum AI; Godefroy F; Weil-Fugazza J
    Brain Res; 1987 Sep; 419(1-2):229-38. PubMed ID: 2445422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoaminergic responses to spinal trauma. Participation of serotonin in posttraumatic progression of neural damage.
    Salzman SK; Hirofuji E; Llados-Eckman C; MacEwen GD; Beckman AL
    J Neurosurg; 1987 Mar; 66(3):431-9. PubMed ID: 2434632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass fragmentographic analysis of monoamine metabolites in the spinal cord of rat after the administration of morphine.
    Commissiong JW
    J Neurochem; 1983 Nov; 41(5):1313-8. PubMed ID: 6194263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of the spinal serotoninergic, noradrenergic and dopaminergic systems in the mechanism of analgesia].
    Weil-Fugazza J
    Cah Anesthesiol; 1994; 42(6):707-12. PubMed ID: 7767717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.
    Scatton B; Javoy-Agid F; Rouquier L; Dubois B; Agid Y
    Brain Res; 1983 Sep; 275(2):321-8. PubMed ID: 6626985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation and modulation of the locomotor pattern in the adult chronic spinal cat by noradrenergic, serotonergic and dopaminergic drugs.
    Barbeau H; Rossignol S
    Brain Res; 1991 Apr; 546(2):250-60. PubMed ID: 2070262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J; Schmidt WJ
    Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R; Ekstedt J; Anggård E
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of the serotonin metabolite, 5-hydroxyindoleacetic acid, in cerebro-spinal fluid and spinal cord of bovines affected with the paraplegic syndrome.
    Lima L; Urbina M; Drujan B
    Acta Cient Venez; 1995; 46(3):161-5. PubMed ID: 9334442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease.
    Jenner P; Sheehy M; Marsden CD
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):277S-289S. PubMed ID: 6337612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
    Palmer AM; Wilcock GK; Esiri MM; Francis PT; Bowen DM
    Brain Res; 1987 Jan; 401(2):231-8. PubMed ID: 2434191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct evidence for the link between monoaminergic descending pathways and motor activity. I. A study with microdialysis probes implanted in the ventral funiculus of the spinal cord.
    Gerin C; Becquet D; Privat A
    Brain Res; 1995 Dec; 704(2):191-201. PubMed ID: 8788914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of spinal cord serotonergic neurons accompanies cold-induced sympathoexcitation.
    Passerin AM; Henley WN
    Can J Physiol Pharmacol; 1994 Aug; 72(8):884-92. PubMed ID: 7530593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered serotonin metabolism in depressed patients with parkinson's disease.
    Mayeux R; Stern Y; Cote L; Williams JB
    Neurology; 1984 May; 34(5):642-6. PubMed ID: 6200801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamines and related substances in brainstem and spinal cord of Lewis rats during the attack and recovery of experimental autoimmune encephalomyelitis.
    Krenger W; Kabiersch A; Honegger CG
    Brain Res; 1989 Jul; 491(2):374-8. PubMed ID: 2475212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two noradrenergic systems in the brain and their interactions with other monoaminergic neurons.
    Kostowski W
    Pol J Pharmacol Pharm; 1979; 31(4):425-36. PubMed ID: 42889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotransmitters, precursors and metabolites in spinal cord and brain of Lewis rats with EAE.
    Honegger CG; Isler H
    Prog Clin Biol Res; 1984; 146():131-8. PubMed ID: 6201886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.